I-Mab (IMAB) Financials
Stock symbol IMAB is outdated, potentially delisted? Maybe it is available on other exchange?
IMAB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2024 | 212.7 million | 11.5 million |
| Sept. 30, 2024 | 232.7 million | 2.1 million |
| June 30, 2024 | 1.8 billion | 17.2 million |
| March 31, 2024 | 2.6 billion | 894.8 million |
IMAB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2024 | ? | ? |
| Sept. 30, 2024 | ? | 2.1 million |
| June 30, 2024 | ? | 8.3 million |
| March 31, 2024 | ? | -13.7 million |
IMAB Net Income
No data available :(
IMAB Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2024 | 173.4 million | 3.1 million | 3.9 million |
| Sept. 30, 2024 | 184.4 million | 431431 | 3.8 million |
| June 30, 2024 | 1.5 billion | 443386 | 4.0 million |
| March 31, 2024 | 2.3 billion | - | - |
IMAB Shares Outstanding
IMAB Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2024 | - | 6.0 million | 7.3 million | - |
| Sept. 30, 2024 | - | 637600 | 1.1 million | - |
| June 30, 2024 | - | 3.1 million | 1.6 million | -10.2 million |
| March 31, 2024 | - | 5.4 million | 7.2 million | 75.3 million |
IMAB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2024 | - | - |
| Sept. 30, 2024 | - | - |
| June 30, 2024 | - | - |
| March 31, 2024 | 4.0 million | -2.9 million |
IMAB Revenue by Segment
Graph available only for paid members. Upgrade to see it.
IMAB
Price: $4.63
52 week price:
Earnings Per Share: -0.51 USD
P/E Ratio: -9.08
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: China
Volume: 425462
Market Capitalization: 378.9 million